Related Experiment Video
Updated: Jul 18, 2025
05:30
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
502
Extracellular Vesicles in Coronary Artery Disease
Naomi Buntsma1,2,3, Edwin van der Pol2,3, Rienk Nieuwland3
1Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Advances in Experimental Medicine and Biology
|August 21, 2023
Summary
Extracellular vesicles (EVs) show promise as blood-based biomarkers for diagnosing coronary artery disease (CAD), predicting patient prognosis, and monitoring therapy. Further research is needed to overcome standardization challenges for clinical application.
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Extracellular Vesicle Biology
Background:
- Coronary artery disease (CAD) remains a leading global cause of mortality and disability.
- Current diagnostic and therapeutic strategies for CAD have limitations, with remaining evidence gaps.
- Novel, minimally invasive biomarkers are needed to address these gaps.
Purpose of the Study:
- To provide an overview of the associations between extracellular vesicles (EVs) and CAD.
- To explore the potential of EVs in CAD pathogenesis, diagnosis, prognosis, and therapy.
- To summarize challenges and future directions for EV clinical applications in CAD.
Main Methods:
- Review of existing literature on EVs and CAD.
- Analysis of the role of EVs in CAD pathogenesis.
- Evaluation of EVs as diagnostic, prognostic, and therapeutic tools.
Main Results:
- EVs are implicated in the pathogenesis of CAD.
- EVs show potential as biomarkers for CAD diagnosis, prognosis, and therapy monitoring.
- EVs may serve as novel therapeutic targets or drug delivery vehicles.
Conclusions:
- EVs represent a promising area for advancing CAD management.
- Standardization in EV isolation and detection is crucial for clinical translation.
- Current knowledge is evolving, necessitating ongoing research and validation.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:30Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
01:30Coronary Artery Disease III: Clinical Manifestations
13
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
01:38Intralumenal Vesicles and Multivesicular Bodies
3.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20